Analysis of Drugs Manual
March 30, 2018
This document is an internal Drug Enforcement Administration quality system document. The effective period of this document is April 24, 2018 to September 9, 2019 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.